A Novel Analytical Method for Pharmaceutical Polymorphs by Terahertz Spectroscopy and the Optimization of Crystal Form at the Discovery Stage
スポンサーリンク
概要
- 論文の詳細を見る
A novel analytical method for the determination of pharmaceutical polymorphs was developed using terahertz spectroscopy. It was found out that each polymorph of a substance showed a specific terahertz absorption spectrum. In particular, analysis of the second derivative spectrum was enormously beneficial in the discrimination of closely related polymorphs that were difficult to discern by powder X-ray diffractometry. Crystal forms that were obtained by crystallization from various solvents and stored under various conditions were specifically characterized by the second derivative of each terahertz spectrum. Fractional polymorphic transformation for substances stored under stressed conditions was also identified by terahertz spectroscopy during solid-state stability test, but could not be detected by powder X-ray diffractometry. Since polymorphs could be characterized clearly by terahertz spectroscopy, further physicochemical studies could be conducted in a timely manner. The development form of compound examined was determined by the results of comprehensive physicochemical studies that included thermodynamic relationships, as well as chemical and physicochemical stability. In conclusion, terahertz spectroscopy, which has unique power in the elucidation of molecular interaction within a crystal lattice, can play more important role in physicochemical research. Terahertz spectroscopy has a great potential as a tool for polymorphic determination, particularly since the second derivative of the terahertz spectrum possesses high sensitivity for pharmaceutical polymorphs.
- 社団法人 日本薬学会の論文
著者
-
Terada Katsuhide
School of Pharmaceutical Sciences, Toho University
-
Ikeda Yukihiro
Discovery Research Center, Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd.
-
Ishihara Yoko
Discovery Research Center, Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd.
-
Moriwaki Toshiya
Discovery Research Center, Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd.
-
Kato Eiji
Advantest Corporation, Ltd.
-
Terada Katsuhide
School Of Pharmaceutical Sciences Toho Univ.
-
Ikeda Yukihiro
Discovery Res. Center Pharmaceutical Res. Div. Takeda Pharmaceutical Co. Ltd.
関連論文
- Study of the Pseudo-Crystalline Transformation from Form I to Form II of Thiamine Hydrochloride (Vitamin B1)
- A Novel Analytical Method for Pharmaceutical Polymorphs by Terahertz Spectroscopy and the Optimization of Crystal Form at the Discovery Stage
- Interaction of Microcrystalline Cellulose and Water in Granules Prepared by a High-Shear Mixer
- Determination of Hydration kinetics of Sulfaguanidine Anhydrate in Aqueous Solution by Calorimetry
- Determination of Heat of Hydration and Hydration Kinetics of Theophylline by Thermal Analysis
- Measurement of Rates of Water Penetration into Tablets by Microcalorimetry
- Evaluation and Mechanism of Crystallite Orientation in Tablets
- Characterization of Polymorphs of a Novel Quinolinone Derivative, TA-270(4-Hydroxy-1-methyl-3-octyloxy-7-sinapinoylamino-2(1H)-quinolinone)
- Freeze-Drying of Proteins in Glass Solids Formed by Basic Amino Acids and Dicarboxylic Acids
- Glass-State Amorphous Salt Solids Formed by Freeze-Drying of Amines and Hydroxy Carboxylic Acids : Effect of Hydrogen-Bonding and Electrostatic Interactions
- Quantitative Determination of Amorphous Nicardipine Hydrochloride in Long Acting Formula (NIC-LA^[○!R]>) Using Light Anhydrous Silicic Acid
- Application and Mechanism of Inhalation Profile Improvement of DPI Formulations by Mechanofusion with Magnesium Stearate
- Novel Approach to DPI Carrier Lactose with Mechanofusion Process with Additives and Evaluation by IGC
- Synthesis of VIP-Lipopeptide using a New Linker to Modify Liposomes: Towards the Development of a Drug Delivery System for Active Targeting